Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000019617-25-000426·ALTERITY THERAPEUTICS LTD
Schedule 13G ownership disclosure
ALTERITY THERAPEUTICS LTD
American Depositary Shares, each representing 600 Ordinary Shares · CUSIP: Q02676106
Event date: 2025-03-31
- Filing-level shares
- 429,671,484
- Percent of class
- 6.3%
- JPMORGAN CHASE & CO.
Shares: 429,671,484 · Class: 6.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000019617-25-000426
- Form type
- SCHEDULE 13G
- Filer
- ALTERITY THERAPEUTICS LTD
- CIK
- CIK 1131343
- Filed
- May 02, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership